Showing 221-230 of 2527 results for "".
Global Perspectives
https://modernod.com/mod-issues/2022-apr/global-perspectives/38409/Can Our Rights Disappear Overnight?
https://modernod.com/mod-issues/2022-mar/can-our-rights-disappear-overnight/38397/The answer may surprise you.A Double-Header: Dry Eye and Filamentary Keratitis
https://modernod.com/mod-issues/2022-mar/a-double-header-dry-eye-and-filamentary-keratitis/38396/This case shows how dehydrated human amniotic membrane can be an effective treatment option for patients with both conditions.How I Became a Believer
https://modernod.com/topics/myopia/how-i-became-a-believer/38395/The author recounts how she came to appreciate that myopia is a serious epidemic and jumped into action to spread the word.Guidelines for Managing Myopia: a Review
https://modernod.com/topics/myopia/guidelines-for-managing-myopia-a-review/38394/Developing a standard of care will improve the lives of patients.Gene Therapy and Inherited Retinal Disease
https://modernod.com/mod-issues/2022-mar/gene-therapy-and-inherited-retinal-disease/38393/Optometry plays a vital role in the management of patients with genetic eye conditions.Vision Screening and US Population Health, Part 2: What You Need to Know
https://modernod.com/mod-issues/2022-mar/vision-screening-and-us-population-health-part-2-what-you-need-to-know/38390/A deeper dive into accessing care and why comprehensive eye examinations remain the best approach to improving population health.Get Prepped for Multifocal Success
https://modernod.com/topics/contact-lenses/get-prepped-for-multifocal-success/38366/Your old bag of tricks will still work with the latest contact lens technology.The Latest Roundup of Key Presbyopia–Correcting Drops
https://modernod.com/topics/technology/the-latest-roundup-of-key-presbyopia-correcting-drops/38364/Watch out for updates on drops in development.Ophthalmic Biologics
https://modernod.com/mod-issues/2021-nov-dec/ophthalmic-biologics/38340/An overview of how these bioengineered molecules are being used in eye care.